ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,162Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 487

$575K Total Retail Price of All Prescriptions

Rank: 23 out of 487

277 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

23% of this provider’s 277 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 277 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 7,654 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
HYDROCODONE-ACETAMINOPHEN 394 262 S3 1 3
SIMVASTATIN 322 246 2 4
LEVOTHYROXINE SODIUM 308 199 3 1
OMEPRAZOLE 298 174 4 2
METFORMIN HCL 265 162 5 8
FUROSEMIDE 249 182 6 7
CARVEDILOL 218 144 7 32
METOPROLOL SUCCINATE 216 164 8 15
AMLODIPINE BESYLATE 213 175 9 6
TRAMADOL HCL 199 105 10 19
ZOLPIDEM TARTRATE 190 76 11 14
MORPHINE SULFATE ER 169 125 S2 12 54
FLUOXETINE HCL 160 95 13 28
CYMBALTA 153 61 14 34
WARFARIN SODIUM 151 150 15 11
HYDROCHLOROTHIAZIDE 145 127 16 9
POTASSIUM CHLORIDE 142 127 17 10
GABAPENTIN 140 98 18 13
LISINOPRIL 138 110 19 5
ISOSORBIDE MONONITRATE ER 126 83 20 79
TAMSULOSIN HCL 121 107 21 25
NEXIUM 120 69 22 41
LOSARTAN POTASSIUM 119 109 23 16
QUINAPRIL HCL 115 83 24 147
CLOPIDOGREL 109 103 25 91
DONEPEZIL HCL 107 105 26 38
NABUMETONE 107 58 26 148
RANITIDINE HCL 99 72 28 39
FENTANYL 98 72 S2 29 36
ROPINIROLE HCL 97 63 30 60
PREDNISONE 93 74 31 37
TRAZODONE HCL 91 68 32 22
METOPROLOL TARTRATE 90 56 33 17
GLIMEPIRIDE 89 68 34 35
LYRICA 84 39 35 77
SPIRONOLACTONE 82 64 36 43
PROAIR HFA 81 60 37 40
BUPROPION XL 80 24 38 97
SERTRALINE HCL 79 64 39 21
MIRTAZAPINE 77 52 40 59
LANTUS 73 62 41 44
PLAVIX 72 67 42 143
SPIRIVA 67 54 43 48
VENLAFAXINE HCL ER 66 34 44 55
MELOXICAM 66 33 44 26
ALLOPURINOL 62 62 46 29
AMOX TR-POTASSIUM CLAVULANATE 62 43 46 124
OXYCONTIN 60 0 S2 48 145
BENAZEPRIL HCL 60 56 48 67
ATORVASTATIN CALCIUM 59 59 50 18
OLANZAPINE 56 36 51 73
DIGOXIN 56 41 51 47
LEVETIRACETAM 55 36 53 130
METOLAZONE 53 37 54 146
DIOVAN 53 41 54 74
POLYETHYLENE GLYCOL 3350 53 34 54 56
GLIPIZIDE ER 52 28 57 95
ATENOLOL 52 37 57 23
METHOCARBAMOL 52 38 R 57 118
SINGULAIR 51 20 60 125
CRESTOR 51 38 60 42
CYCLOBENZAPRINE HCL 50 0 R 62 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.